(Q73900839)
Statements
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196 (English)
J A Sparano
A O'Neill
P L Schaefer
C I Falkson